HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 3 filers reported holding HEALTH CATALYST INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $410,764 | +188.5% | 41,420 | +266.8% | 0.00% | – |
Q2 2023 | $142,403 | -37.5% | 11,293 | +31.0% | 0.00% | – |
Q1 2022 | $228,000 | -78.1% | 8,622 | -67.2% | 0.00% | -100.0% |
Q4 2021 | $1,042,000 | -25.3% | 26,282 | -5.7% | 0.00% | 0.0% |
Q3 2021 | $1,394,000 | +311.2% | 27,873 | +358.7% | 0.00% | – |
Q2 2021 | $339,000 | – | 6,076 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |